TY  - GEN
AU  - Iyer,Gopa
AU  - Balar,Arjun V
AU  - Milowsky,Matthew I
AU  - Bochner,Bernard H
AU  - Dalbagni,Guido
AU  - Donat,S Machele
AU  - Herr,Harry W
AU  - Huang,William C
AU  - Taneja,Samir S
AU  - Woods,Michael
AU  - Ostrovnaya,Irina
AU  - Al-Ahmadie,Hikmat
AU  - Arcila,Maria E
AU  - Riches,Jamie C
AU  - Meier,Andreas
AU  - Bourque,Caitlin
AU  - Shady,Maha
AU  - Won,Helen
AU  - Rose,Tracy L
AU  - Kim,William Y
AU  - Kania,Brooke E
AU  - Boyd,Mariel E
AU  - Cipolla,Catharine K
AU  - Regazzi,Ashley M
AU  - Delbeau,Daniela
AU  - McCoy,Asia S
AU  - Vargas,Hebert Alberto
AU  - Berger,Michael F
AU  - Solit,David B
AU  - Rosenberg,Jonathan E
AU  - Bajorin,Dean F
TI  - Multicenter Prospective Phase II Trial of Neoadjuvant Dose-Dense Gemcitabine Plus Cisplatin in Patients With Muscle-Invasive Bladder Cancer
SN  - 1527-7755
PY  - 2019///0812
KW  - Adult
KW  - Aged
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - adverse effects
KW  - Chemotherapy, Adjuvant
KW  - Cisplatin
KW  - administration & dosage
KW  - Cystectomy
KW  - Deoxycytidine
KW  - Disease-Free Survival
KW  - Female
KW  - Filgrastim
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Neoadjuvant Therapy
KW  - Neoplasm Invasiveness
KW  - Neoplasm Recurrence, Local
KW  - diagnostic imaging
KW  - Neoplasm Staging
KW  - Polyethylene Glycols
KW  - Prospective Studies
KW  - Urinary Bladder Neoplasms
KW  - Gemcitabine
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1200/JCO.2017.75.0158
ER  -